sustained manner and to minimize the side effects.This research was carried out for development of drug loaded oral Sustained-release pellets by membrane –matrix hybrid technology of water soluble drug…
attempt to develop and evaluate an oral fast dissolving drug delivery system using Musa paradisiaca powder as a novel superdisintegrant. Materials and methods: The formulation contains a model drug (Montelukast…
solvent system) which could increase the solubility as well as stabilized the developed oral solution (syrup) formulation ... basis of solubility studies mixed solvent oral solution formulations of aceclofenac were…
purpose of present study was to develop controlled release microspheres for oral delivery of Aceclofenac. The microspheres were prepared by Oil-in-Oil (O/O) emulsion solvent evaporation technique using ... phosphate…
patient; extended life cycle, product differentiation, patent protection. But there are some challenges for formulation development studies for the generic companies. In the sense of generic companies, developing a Fast
well as microcapsules, nanoparticules or micro emulsions. But there are some limitations for formulation development studies like drug stability, poor solubility, packaging, controlling the quality of these unique…
formulation and exploratory formulation development studies are critical in defining drug product strategies for first in human studies leading to commercial dosage form development. Exploratory development is a dynamic…
Activities done prior to formulation development are called as preformulation studies. It provides the scientific basis for formulation development. Preformulation studies can be broadly classified into two classes –…
were developed for t10%, t50%, t75%, t90%. Validity of developed polynomial equations were verified by designing 2 check point formulations(C1, C2). According to SUPAC guidelines the formulation (F5) containing
been investigated to develop combination of sustained and immediate release formulations. The present study aims to develop and evaluate to provide a combined therapy through a single tablet in which
Etodolac 600 mg. Based on the pre-formulation studies; excipients are selected for formulation development. The major criterion considered during the development of formulation was to match the dissolution profile
oral mucosa. Loratadine was selected as a model drug for the study. MMD was developed by a direct compression method using a rotary compressed tablet machine using water soluble ... were characterized for uniformity of…
when administered as I.V. injection. The main objective of present study was to develop a stable formulation and manufacturing process of Ibandronate sodium injection 3mg/3mL. As a part